You just read:

Glenmark Receives Approval From the Regulator (DCGI) to Conduct Clinical Trials in India on Favipiravir Antiviral Tablets for COVID-19 Patients

News provided by

Glenmark Pharmaceuticals Ltd.

30 Apr, 2020, 10:32 IST